| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |